Literature DB >> 22156043

The aporphine alkaloid boldine improves endothelial function in spontaneously hypertensive rats.

Yeh-Siang Lau1, Ajay Machha, Francis I Achike, Dharmani Murugan, Mohd Rais Mustafa.   

Abstract

Boldine, a major aporphine alkaloid found in Chilean boldo tree, is a potent antioxidant. Oxidative stress plays a detrimental role in the pathogenesis of endothelial dysfunction in hypertension. In the present study, we investigated the effects of boldine on endothelial dysfunction in hypertension using spontaneously hypertensive rats (SHR), the most studied animal model of hypertension. SHR and their age-matched normotensive Wistar-Kyoto (WKY) rats were treated with boldine (20 mg/kg per day) or its vehicle, which served as control, for seven days. Control SHR displayed higher systolic blood pressure (SBP), reduced endothelium-dependent aortic relaxation to acetylcholine (ACh), marginally attenuated endothelium-independent aortic relaxation to sodium nitroprusside (SNP), increased aortic superoxide and peroxynitrite production, and enhanced p47(phox) protein expression as compared with control WKY rats. Boldine treatment significantly lowered SBP in SHR but not in WKY. Boldine treatment enhanced the maximal relaxation to ACh in SHR, but had no effect in WKY, whereas the sensitivity to ACh was increased in both SHR and WKY aortas. Boldine treatment enhanced sensitivity, but was without effect on maximal aortic relaxation responses, to SNP in both WKY and SHR aortas. In addition, boldine treatment lowered aortic superoxide and peroxynitrite production and downregulated p47(phox) protein expression in SHR aortas, but had no effect in the WKY control. These results show that boldine treatment exerts endothelial protective effects in hypertension, achieved, at least in part, through the inhibition of NADPH-mediated superoxide production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156043     DOI: 10.1258/ebm.2011.011145

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  7 in total

1.  Boldine improves endothelial function in diabetic db/db mice through inhibition of angiotensin II-mediated BMP4-oxidative stress cascade.

Authors:  Yeh Siang Lau; Xiao Yu Tian; Mohd Rais Mustafa; Dharmani Murugan; Jian Liu; Yang Zhang; Chi Wai Lau; Yu Huang
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  Endothelial NO and O₂·⁻ production rates differentially regulate oxidative, nitroxidative, and nitrosative stress in the microcirculation.

Authors:  Saptarshi Kar; Mahendra Kavdia
Journal:  Free Radic Biol Med       Date:  2013-04-29       Impact factor: 7.376

Review 3.  Boldine Ameliorates Vascular Oxidative Stress and Endothelial Dysfunction: Therapeutic Implication for Hypertension and Diabetes.

Authors:  Yeh Siiang Lau; Wei Chih Ling; Dharmani Murugan; Mohd Rais Mustafa
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

4.  Cerebrovascular Protective Effect of Boldine Against Neural Apoptosis via Inhibition of Mitochondrial Bax Translocation and Cytochrome C Release.

Authors:  Xiaozhong Qiu; Ling Shi; Hanting Zhuang; Hongtao Zhang; Juan Wang; Lijun Wang; Peng Sun; Lili Yu; Longxi Liu
Journal:  Med Sci Monit       Date:  2017-08-25

5.  Boldine Improves Kidney Damage in the Goldblatt 2K1C Model Avoiding the Increase in TGF-β.

Authors:  Gonzalo I Gómez; Victoria Velarde
Journal:  Int J Mol Sci       Date:  2018-06-25       Impact factor: 5.923

Review 6.  Natural Aporphine Alkaloids with Potential to Impact Metabolic Syndrome.

Authors:  Fei-Xuan Wang; Nan Zhu; Fan Zhou; Dong-Xiang Lin
Journal:  Molecules       Date:  2021-10-10       Impact factor: 4.411

7.  Boldine, an Alkaloid from Peumus boldus Molina, Induces Endothelium-Dependent Vasodilation in the Perfused Rat Kidney: Involvement of Nitric Oxide and Small-Conductance Ca2+-Activated K+ Channel.

Authors:  Priscila de Souza; Rita de Cássia Vilhena da Silva; Luisa Mota da Silva; Viviane Miranda Bispo Steimbach; Karyne Garcia Tafarelo Moreno; Arquimedes Gasparotto Junior
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-16       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.